Navigation Links
Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
Date:3/14/2008

of matter, production methods and therapeutic uses of the drug.

Merrimack Pharmaceuticals, Inc., is a biotechnology company focused on the discovery and development of novel treatments for diseases in the areas of autoimmunity and cancer. Its lead compound, MM-093, is currently in clinical development to treat patients with rheumatoid arthritis or with autoimmune uveitis. MM-093 is an investigational drug and has not been approved by the U.S. Food and Drug Administration or any international regulatory agency. The company's proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, enables the high throughput profiling of protein networks as a basis for improved validation, lead identification and speed in the development of innovative, effective and safe therapeutics. Merrimack is a privately-held company based in Cambridge, Massachusetts. For additional information, please visit http://www.merrimackpharma.com.

Contact: Kathleen Petrozzelli, Senior Manager, Corporate Communications,

617-441-1043


'/>"/>
SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
2. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
3. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
4. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
7. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
8. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
9. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
10. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
11. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... April 16, 2015 Mindray Medical International ... and marketer of medical devices worldwide, announced today ... Exchange Commission an Annual Report on Form 20-F that ... 31, 2014. An electronic version of Mindray,s Annual ... investor relations website at  http://ir.mindray.com  or  http://www.sec.gov . ...
(Date:4/16/2015)... 16, 2015  Hologic, Inc. (NASDAQ: HOLX ... study i published on-line this week in ... the American Cancer Society. The study, ... Pittsburgh Medical Center, supports current consensus guidelines ii ... 30-65 years of age be co-tested with both ...
(Date:4/16/2015)... Calif. , April 16, 2015  Amgen (NASDAQ: ... its first quarter financial results on Tuesday, April 21, ... The announcement will be followed by a conference call ... in the call from Amgen will be Robert ... other members of Amgen,s senior management team. ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Amgen Announces Webcast Of 2015 First Quarter Financial Results 2
... ANDOVER, Mass., Jan. 18, 2011 MKS Instruments, Inc. (Nasdaq: ... enable advanced processes and improve productivity, today announced that it ... after market close on Wednesday, February 2, 2011.  A conference ... 2011 at 8:30 a.m. (eastern time). The call will be ...
... U.S. Food and Drug Administration today announced that the ... entered a consent decree of permanent injunction against Deltex ... and vice president, Mohidur R. Khan. ... permanently prohibits/stops the company, Ahmed, and Khan from manufacturing ...
Cached Medicine Technology:Federal Government Obtains Permanent Injunction Against Deltex Pharmaceuticals Inc. 2
(Date:4/18/2015)... Thousand of DePuy Pinnacle hip lawsuits ... who were allegedly harmed by a metal-on-metal version of ... the U.S. District Court, Northern District of Texas. According ... amended an earlier Case Management Order to allow for ... new amendment permits the claims of up to 150 ...
(Date:4/18/2015)... 2015 “ ArcAngel ” was featured on ... look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... app. , In a turbulent world, people may find ... should always be their first move, but some situations can ...
(Date:4/17/2015)... New York, NY (PRWEB) April 18, 2015 ... services at their facility, rounding out their list of ... comprehensive care center for patients on the Upper East ... up and running at full capacity. The addition of ... Accelerator, gives their physicians the ability to work with ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 “We have seen ... of the past and present,” said Chaplain Shawn Kafader of ... hadn’t felt like they had anything to contribute have created ... has overseen a new art therapy program that was launched ... a Masters student from School of the Art Institute in ...
(Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will be coming ... event will be held in the heart of downtown Grand ... Grand Rapids, MI 49503) and will feature wine personalities and ... encouraged to savor the food and beverage pairings while enjoying ... will feature seven chefs, including:, Chef ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Healing At Friendship Village Due To Art Therapy 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2
... 9 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... the development, manufacture and commercialization of,a broad range of ... announced financial results for the fourth quarter and fiscal ... Financial Results , Revenue in ...
... of baby boomers with eye-ailments and soaring medical ... diet supplements to protect their eyes and curb ... supplements to alleviate blinding diseases such as age-related ... growth avenues in the market.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... (Dublin, Ohio), the psychiatric practice of Adam Brandemihl, M.D., Board Certified ... Adult ADD. He discusses ten ways of coping with adult ADD ... ... 9, 2009 -- With the continued recession and struggling economy, keeping ...
... as the community,s new medical director. White, a Board-certified internal and ... substantial, relevant experience to Park Springs, a continuing care retirement community ... ... March 6, 2009 -- Park Springs is pleased to announce Dr. ...
... treatment provider and renowned male hormone replacement experts ... publicity concerning professional athletes within MLB testing positive ... growth hormone) may have on men suffering from ... negative image being portrayed by professional athletes -- ...
... analysis has found that certain variations in genes that ... Hodgkin disease. Published in the April 1, 2009 issue ... American Cancer Society, the study indicates that differences in ... individuals, susceptibility to this type of cancer. , Proteins ...
Cached Medicine News:Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results 9Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 2Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 3Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 4Health News:Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market 5Health News:How to Win the Battle with Adult ADD in the Workplace 2Health News:How to Win the Battle with Adult ADD in the Workplace 3Health News:Park Springs Names New Medical Director 2Health News:Park Springs Names New Medical Director 3Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 2Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 3Health News:Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity 4Health News:DNA differences may influence risk of Hodgkin disease 2
... based on the competition principle and the ... present in the sample and a fixed ... compete for the binding sites of a ... After one hour incubation the microtiterplate is ...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM....
Latex agglutination test for the qualitative and semiquantitative determination of rheumatoid factor in serum....
... with the SYNCHRON CX4 PRO, which ... and automated technologies, your laboratory can ... The SYNCHRON CX4 PRO consolidates DATs, ... tests, such as thyroid, HbA1c and ...
Medicine Products: